Business Description
Guilin Sanjin Pharmaceutical Co Ltd
NAICS : 325414
SIC : 2836
ISIN : CNE100000DY9
Share Class Description:
SZSE:002275: Class ACompare
Compare
Traded in other countries / regions
002275.China IPO Date
2009-07-10Description
Guilin Sanjin Pharmaceutical Co Ltd is engaged in research and development of proprietary Chinese medicines and natural medicines.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.75 | |||||
| Equity-to-Asset | 0.77 | |||||
| Debt-to-Equity | 0.17 | |||||
| Debt-to-EBITDA | 1.02 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 7.68 | |||||
| Beneish M-Score | -2.64 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 11 | |||||
| 3-Year EBITDA Growth Rate | 13.7 | |||||
| 3-Year EPS without NRI Growth Rate | 13.9 | |||||
| 3-Year FCF Growth Rate | 5.9 | |||||
| 3-Year Book Growth Rate | -1.5 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 43.67 | |||||
| 9-Day RSI | 45.23 | |||||
| 14-Day RSI | 47.84 | |||||
| 6-1 Month Momentum % | 10.17 | |||||
| 12-1 Month Momentum % | -3.45 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | |||||
| Quick Ratio | 3.37 | |||||
| Cash Ratio | 2.38 | |||||
| Days Inventory | 170.44 | |||||
| Days Sales Outstanding | 32 | |||||
| Days Payable | 56.24 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.73 | |||||
| Dividend Payout Ratio | 0.87 | |||||
| 3-Year Dividend Growth Rate | 44.9 | |||||
| Forward Dividend Yield % | 5.76 | |||||
| 5-Year Yield-on-Cost % | 15.64 | |||||
| 3-Year Average Share Buyback Ratio | 0.1 | |||||
| Shareholder Yield % | 4.4 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 73.93 | |||||
| Operating Margin % | 23.15 | |||||
| Net Margin % | 19.31 | |||||
| FCF Margin % | 23.01 | |||||
| ROE % | 13.94 | |||||
| ROA % | 10.57 | |||||
| ROIC % | 18.34 | |||||
| ROC (Joel Greenblatt) % | 38.26 | |||||
| ROCE % | 15.75 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 21.33 | |||||
| PE Ratio without NRI | 21.27 | |||||
| Shiller PE Ratio | 20.44 | |||||
| Price-to-Owner-Earnings | 29.07 | |||||
| PEG Ratio | 7.6 | |||||
| PS Ratio | 4.09 | |||||
| PB Ratio | 2.87 | |||||
| Price-to-Tangible-Book | 3.02 | |||||
| Price-to-Free-Cash-Flow | 17.88 | |||||
| Price-to-Operating-Cash-Flow | 15.75 | |||||
| EV-to-EBIT | 15.43 | |||||
| EV-to-EBITDA | 15.43 | |||||
| EV-to-Revenue | 3.67 | |||||
| EV-to-FCF | 16.07 | |||||
| Price-to-Projected-FCF | 1.46 | |||||
| Price-to-DCF (Earnings Based) | 1.84 | |||||
| Price-to-DCF (FCF Based) | 0.57 | |||||
| Price-to-Median-PS-Value | 0.82 | |||||
| Price-to-Graham-Number | 1.69 | |||||
| Price-to-Net-Current-Asset-Value | 6.43 | |||||
| Price-to-Net-Cash | 17.32 | |||||
| Earnings Yield (Greenblatt) % | 6.48 | |||||
| FCF Yield % | 5.65 | |||||
| Forward Rate of Return (Yacktman) % | 7.34 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Guilin Sanjin Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 2,114.623 | ||
| EPS (TTM) (Â¥) | 0.69 | ||
| Beta | 1.02 | ||
| Volatility % | 32.14 | ||
| 14-Day RSI | 47.84 | ||
| 14-Day ATR (Â¥) | 0.39355 | ||
| 20-Day SMA (Â¥) | 14.9415 | ||
| 12-1 Month Momentum % | -3.45 | ||
| 52-Week Range (Â¥) | 11.28 - 16.99 | ||
| Shares Outstanding (Mil) | 587.57 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Guilin Sanjin Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Guilin Sanjin Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Guilin Sanjin Pharmaceutical Co Ltd Frequently Asked Questions
What is Guilin Sanjin Pharmaceutical Co Ltd(SZSE:002275)'s stock price today?
The current price of SZSE:002275 is ¥14.72. The 52 week high of SZSE:002275 is ¥16.99 and 52 week low is ¥11.28.
When is next earnings date of Guilin Sanjin Pharmaceutical Co Ltd(SZSE:002275)?
The next earnings date of Guilin Sanjin Pharmaceutical Co Ltd(SZSE:002275) is .
Does Guilin Sanjin Pharmaceutical Co Ltd(SZSE:002275) pay dividends? If so, how much?
The Dividend Yield %  of Guilin Sanjin Pharmaceutical Co Ltd(SZSE:002275) is 3.73% (As of Today), Highest Dividend Payout Ratio of Guilin Sanjin Pharmaceutical Co Ltd(SZSE:002275) was 2.37. The lowest was 0.52. And the median was 0.77. The  Forward Dividend Yield % of Guilin Sanjin Pharmaceutical Co Ltd(SZSE:002275) is 5.76%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers